TECHNOLOGY LICENSING OPPORTUNITY: DC Recruiter
ENERGY, DEPARTMENT OF
Place of performance: Los Alamos, NM
Free. Verify your email, then we send one reminder only.
- Posted
- Jun 16, 2026
- Closes
- Dec 16, 2026 (in 138 days)
Similar opportunities open now
- TECHNOLOGY LICENSING OPPORTUNITY: DC RecruiterOpenENERGY, DEPARTMENT OFCloses Dec 2026
- TECHNOLOGY LICENSING OPPORTUNITY: NanoFETOpenENERGY, DEPARTMENT OFCloses Dec 2026
- TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs PlatformOpenENERGY, DEPARTMENT OFCloses Dec 2026
- TECHNOLOGY LICENSING OPPORTUNITY: SurfGraphProOpenENERGY, DEPARTMENT OFCloses Dec 2026
- TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics PlatformOpenENERGY, DEPARTMENT OFCloses Dec 2026
At a glance
This is a government contract opportunity posted by ENERGY, DEPARTMENT OF in the research and development in biotechnology (except nanobiotechnology) category. The deadline is December 16, 2026, 138 days from now. Work is performed in Los Alamos, NM.
Classification and identifiers
- Industry (NAICS)
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- Product or service (PSC)
- General Science & Technology R&D Svcs; General Science & Technology; Experimental Development (AJ13)
- Solicitation number
- S-195061
- Contracting office
- TRIAD - DOE CONTRACTOR
Who can apply
No Set aside used. NONE
About this opportunity
DC Recruiter: Broad-Spectrum Immune Enhancer from scientists at Los Alamos National Laboratory offers a differentiated approach to multi-pathogen infection prevention by using a self-assembling peptide nanofiber to recruit and activate dendritic cells (DCs), the immune system�s natural sentinels. Unlike pathogen-specific vaccines or therapeutics, it is designed to help trigger an early immune response regardless of the infecting agent. Its needle-free, spray-friendly concept adds practicality. The Challenge: DC Recruiter addresses a persistent and highly consequential gap in infection management: the need for a rapid, broadly effective way to stimulate immune defense before the specific pathogen is known. In many exposure scenarios, the body encounters a threat before clinicians can identi...
Related opportunities
- TECHNOLOGY LICENSING OPPORTUNITY: DC RecruiterENERGY, DEPARTMENT OFCloses Dec 2026
- TECHNOLOGY LICENSING OPPORTUNITY: NanoFETENERGY, DEPARTMENT OFCloses Dec 2026
- TECHNOLOGY LICENSING OPPORTUNITY: NanoFETENERGY, DEPARTMENT OFCloses Dec 2026
- TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs PlatformENERGY, DEPARTMENT OFCloses Dec 2026
- TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs PlatformENERGY, DEPARTMENT OFCloses Dec 2026
- TECHNOLOGY LICENSING OPPORTUNITY: SurfGraphProENERGY, DEPARTMENT OFCloses Dec 2026